Chloracne, "the hallmark of dioxin intoxication"
- PMID: 2930898
- DOI: 10.5271/sjweh.2240
Chloracne, "the hallmark of dioxin intoxication"
Abstract
Clinical experiences and laboratory studies are described involving a population of workers who were exposed in a plant making 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), including a trichlorophenol runaway reaction. Workers were followed for a period of four years, and 30 years later a mortality analysis was done on those exposed to runaway reaction material to determine possible increased risks for causes of death. Subsequently, a morbidity study on 436 employees involving three cohorts was carried out to determine the long-term health effects associated with the production of 2,4,5-T including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). The mortality and morbidity studies demonstrated that the standardized mortality ratio for all causes of death was 69, and for cancer at all sites and cardiovascular disease it was 100 and 68, respectively. The most significant observations emerging from the morbidity study were that 86% of the exposed persons developed chloracne at some time and that 52.7% still had chloracne on examination 20 to 30 years after the initial exposure. There appeared to be no evidence, on a long-term basis, of increased risks for cardiovascular disease, hepatic disease, renal disease, central and peripheral nerve problems, reproductive problems, or birth defects among the exposed and those who had chloracne among the exposed. Studies on the cell kinetics and pathogenesis of chloracne indicate that TCDD induces the modulation of undifferentiated sebaceous gland cells to keratinocytes. This action results in a disappearance of sebaceous glands and substitution of closed comedones and keratin cysts. Production workers have the highest frequency and severity of chloracne and systemic effects.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Cutaneous histologic findings in chemical workers with and without chloracne with past exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.J Am Acad Dermatol. 1985 Mar;12(3):497-506. doi: 10.1016/s0190-9622(85)70070-9. J Am Acad Dermatol. 1985. PMID: 3157708
-
Chloracne and morbidity after dioxin exposure (preliminary results).Toxicol Lett. 1998 Aug;96-97:347-50. doi: 10.1016/s0378-4274(98)00092-7. Toxicol Lett. 1998. PMID: 9820687
-
Human health effects of 2,4,5-T and its toxic contaminants.JAMA. 1984 May 11;251(18):2372-80. JAMA. 1984. PMID: 6231388
-
Chloracne. Some recent issues.Dermatol Clin. 1994 Jul;12(3):569-76. Dermatol Clin. 1994. PMID: 7923954 Review.
-
A proposed occupational exposure limit for 2,3,7,8-tetrachlorodibenzo-p-dioxin.Am Ind Hyg Assoc J. 1988 Sep;49(9):466-74. doi: 10.1080/15298668891380088. Am Ind Hyg Assoc J. 1988. PMID: 2972183 Review.
Cited by
-
2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated production of reactive oxygen species is an essential step in the mechanism of action to accelerate human keratinocyte differentiation.Toxicol Sci. 2013 Mar;132(1):235-49. doi: 10.1093/toxsci/kfs325. Epub 2012 Nov 14. Toxicol Sci. 2013. PMID: 23152189 Free PMC article.
-
Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme.Environ Health Perspect. 1995 Apr;103(4):366-71. doi: 10.1289/ehp.95103366. Environ Health Perspect. 1995. PMID: 7607137 Free PMC article.
-
Environmental pollution and acne: Chloracne.Dermatoendocrinol. 2009 May;1(3):125-8. doi: 10.4161/derm.1.3.7862. Dermatoendocrinol. 2009. PMID: 20436879 Free PMC article.
-
Biomarkers for Great Lakes priority contaminants: halogenated aromatic hydrocarbons.Environ Health Perspect. 1995 Dec;103 Suppl 9(Suppl 9):7-16. doi: 10.1289/ehp.95103s97. Environ Health Perspect. 1995. PMID: 8635442 Free PMC article. Review.
-
Effects of Acute 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Exposure on the Circulating and Cecal Metabolome Profile.Int J Mol Sci. 2021 Oct 30;22(21):11801. doi: 10.3390/ijms222111801. Int J Mol Sci. 2021. PMID: 34769237 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical